Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.
about
Trends in HPV cervical and seroprevalence and associations between oral and genital infection and serum antibodies in NHANES 2003-2012The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinomaAcquisition of new infection and clearance of type-specific human papillomavirus infections in female students in Busan, South Korea: a follow-up studySeroprevalence of 34 human papillomavirus types in the German general population.Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission modelPrevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?HPV prevalence and type distribution in Cypriot women with cervical cytological abnormalities.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.Clinical impact of de-regulated Notch-1 and Notch-3 in the development and progression of HPV-associated different histological subtypes of precancerous and cancerous lesions of human uterine cervix.Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China.Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile.Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisTALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cellsProteomic patterns of cervical cancer cell lines, a network perspective.Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load.Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities.Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.Anogenital malignancies and pre-malignancies.HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study.Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study.Analysis and prediction of pathways in HeLa cells by integrating biological levels of organization with systems-biology approachesViral load in the natural history of human papillomavirus type 16 infection: a nested case-control studyType-specific persistence or regression of human papillomavirus genotypes in women with cervical intraepithelial neoplasia 1: A prospective cohort study.The role of acquired immunity in the spread of human papillomavirus (HPV): explorations with a microsimulation model.Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure.Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda.Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study.Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain.The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya.Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: where is the greatest benefit for cervical cancer prevention in Italy?Cervical human papillomavirus screening among older womenShort-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly.Transmission heterogeneity and autoinoculation in a multisite infection model of HPVPrevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma.Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global reviewHigh-risk HPV type-specific clearance rates in cervical screening.Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UKHuman papillomavirus infection in Shenyang City, People's Republic of China: A population-based study.The predicted effect of changes in cervical screening practice in the UK: results from a modelling study
P2860
Q27312453-F81AB054-5FA6-4472-B740-451A5BB53869Q28387851-31B4D3F3-5F8A-43DF-9501-72A1FF77306CQ33317425-4F836FDF-815F-4767-958F-3858E67FB1BCQ33345224-AE5C14F8-516E-4181-923D-40820B697CBBQ33488325-385D0F77-3D64-4CE0-9BB7-051F745666A6Q33644013-85B1BE7D-5C87-4528-9F41-3D31E0B28827Q33696724-A2944B9C-23CE-4B49-9600-D756A7B54C12Q33698774-653618CA-7D24-43E7-8DAC-D724D81A240DQ33721304-8B026D9A-96F8-4C42-A177-D170AF138906Q33746081-3B1D75CE-1570-4290-B219-A22420090FC8Q33863369-EC255219-202D-4344-A3A6-42A36EAFEC21Q33869018-43A736F9-5970-47E6-A787-B25CD8BF8BB3Q33883532-5205B050-E6FB-45D2-987A-6350578B5998Q33905878-81B2B94C-E10D-4F03-A9A9-135ADFFC8FBCQ33940201-AA8E41E0-E03B-4A32-9856-D7B313C19B75Q34062235-66D541FC-AC80-4215-B991-D388AEB33FF4Q34074208-E38E81BF-0E5F-4D3D-BAF7-71D6D0641255Q34146342-68A06443-27CD-47AC-A704-FDD4B77358CCQ34161073-116D04C7-A6A5-423D-8FF8-5E5104D023C7Q34448633-CDD86ECA-63C7-4752-8DA0-81C0CC7BD635Q34467791-106A1A1B-E295-4253-A175-37FC46CA544AQ34778702-CE901AE1-0D9B-42C1-A271-E09C5B815994Q34834113-C2440C48-99E8-4EA1-9A19-C49B396CD487Q35003285-5E821CB0-218C-463E-897F-C751DCB49958Q35038766-EC5A14CF-5449-4AD6-B57A-2BD7D628BA58Q35111092-A8E26201-B665-4814-A2B6-47805811D3A6Q35172338-167A3462-3F24-4072-9A50-4AB15E48DBFCQ35567403-F3A8F31F-3B7D-451F-BFF2-23C814DB1FF8Q35572951-2E20C8FD-265B-447F-B9EF-1E692B61EC0FQ35619561-0ADD8E04-55A7-47FF-8766-273C031A4678Q35779425-CD9960D4-30F0-4E0F-B0F8-2432C3EAAEBCQ36008704-53EAB102-A0C3-43EA-A1F6-FB9B8197271DQ36116209-45BC1BEE-2BAA-4D5B-8253-D863C1BD381DQ36366560-342321CE-A11B-44BE-BEDB-2F49805FE98DQ36541670-F59ECEA3-B2E4-4E64-BC81-995009BD07CFQ36609068-C997D5F6-59F6-4A9C-9D6C-8EFB823D050AQ36610417-29E26665-B69F-48A6-8815-E855FD7B67C7Q36610489-EBE67F4B-B6E1-4197-934F-76A24C6692BCQ36612491-4DC8D979-1789-4816-A323-D0809B7E0911Q36695433-B0433083-7600-42DE-8611-55B80791F066
P2860
Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Determinants of clearance of h ...... based, 5-year follow-up study.
@en
Determinants of clearance of h ...... based, 5-year follow-up study.
@nl
type
label
Determinants of clearance of h ...... based, 5-year follow-up study.
@en
Determinants of clearance of h ...... based, 5-year follow-up study.
@nl
prefLabel
Determinants of clearance of h ...... based, 5-year follow-up study.
@en
Determinants of clearance of h ...... based, 5-year follow-up study.
@nl
P2093
P50
P356
P1476
Determinants of clearance of h ...... based, 5-year follow-up study.
@en
P2093
Adriaan Van den Brule
Annie Arslan
Chris J L M Meijer
HPV Study Group
Hector Posso
Monica Molano
Nubia Muñoz
P304
P356
10.1093/AJE/KWG171
P407
P577
2003-09-01T00:00:00Z